agilon health (NYSE:AGL) Trading Up 8.5% Following Analyst Upgrade

agilon health, inc. (NYSE:AGL) was up 8.5% during trading on Thursday after Sanford C. Bernstein raised their price target on the stock from $2.50 to $3.15. Sanford C. Bernstein currently has a market perform rating on the stock. agilon health traded as high as $3.07 and last traded at $3.06. Approximately 2,185,717 shares were traded during trading, a decline of 49% from the average daily volume of 4,326,648 shares. The stock had previously closed at $2.82.

A number of other equities research analysts have also recently commented on the stock. JMP Securities cut shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. TD Cowen dropped their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Bank of America cut shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target on the stock. in a research note on Wednesday, October 2nd. Barclays dropped their price target on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Finally, Stifel Nicolaus dropped their price target on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. Two analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $4.03.

Insiders Place Their Bets

In related news, Director Diana Mckenzie purchased 12,500 shares of agilon health stock in a transaction dated Monday, November 25th. The shares were acquired at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the acquisition, the director now directly owns 51,319 shares in the company, valued at approximately $117,007.32. The trade was a 32.20 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John William Wulf purchased 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The shares were bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 90,000 shares of company stock valued at $198,100 in the last 90 days. 3.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AGL. Oak Thistle LLC purchased a new position in shares of agilon health during the 4th quarter worth $25,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in agilon health in the 3rd quarter valued at about $28,000. Pines Wealth Management LLC purchased a new stake in agilon health in the 4th quarter valued at about $51,000. City State Bank purchased a new stake in agilon health in the 3rd quarter valued at about $52,000. Finally, Aigen Investment Management LP purchased a new stake in agilon health in the 3rd quarter valued at about $79,000.

agilon health Stock Performance

The stock has a market capitalization of $1.26 billion, a PE ratio of -3.26 and a beta of 0.53. The firm’s fifty day moving average is $2.07 and its 200-day moving average is $3.67. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health (NYSE:AGL) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter last year, the firm posted ($0.06) earnings per share. As a group, research analysts anticipate that agilon health, inc. will post -0.59 earnings per share for the current year.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.